EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

GOLPH3-mTOR Crosstalk and Glycosylation: A Molecular Driver of Cancer Progression

Anna Frappaolo, Gianluca Zaccagnini, Maria Grazia Giansanti iD

Cells · 14.03.2025 · 14 (6) · 439

DOI: 10.3390/cells14060439 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 14.03.2025. Verfasst von Anna Frappaolo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Biologia e Patologia Molecolari del CNR, c/o Dipartimento di Biologia e Biotecnologie, Sapienza Università di Roma, 00185 Roma, Italy. Hauptthemen laut MEDLINE: Neoplasms, TOR Serine-Threonine Kinases, Membrane Proteins, Disease Progression. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Ministero dell'università e della ricerca, Fondazione AIRC per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Originally identified in proteomic-based studies of the Golgi, Golgi phosphoprotein 3 (GOLPH3) is a highly conserved protein from yeast to humans. GOLPH3 localizes to the Golgi through the interaction with phosphatidylinositol-4-phosphate and is required for Golgi architecture and vesicular trafficking. Many studies revealed that the overexpression of GOLPH3 is associated with tumor metastasis and a poor prognosis in several cancer types, including breast cancer, glioblastoma multiforme, and colon cancer. The purpose of this review article is to provide the current progress of our understanding of GOLPH3 molecular and cellular functions, which may potentially reveal therapeutic avenues to inhibit its activity. Specifically, recent papers have demonstrated that GOLPH3 protein functions as a cargo adaptor for COP I-coated intra Golgi vesicles and impinges on Golgi glycosylation pathways. In turn, GOLPH3-dependent defects have been associated with malignant phenotypes in cancer cells. Additionally, the oncogenic activity of GOLPH3 has been linked with enhanced signaling downstream of mechanistic target of rapamycin (mTOR) in several cancer types. Consistent with these data, GOLPH3 controls organ growth in Drosophila by associating with mTOR signaling proteins. Finally, compelling evidence demonstrates that GOLPH3 is essential for cytokinesis, a process required for the maintenance of genomic stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTOR Serine-Threonine KinasesMembrane ProteinsDisease ProgressionHumansGlycosylationAnimalsSignal TransductionGolgi Apparatus

Stichwörter der Autor:innen

DrosophilaGOLPH3Golgi glycosylationmTOR

Substanzen

TOR Serine-Threonine KinasesMembrane ProteinsGOLPH3 protein, humanMTOR protein, human

Autor:innen und Institutionen

  • Istituto di Biologia e Patologia Molecolari del CNR, c/o Dipartimento di Biologia e Biotecnologie, Sapienza Università di Roma, 00185 Roma, Italy.

ORCID-Profile: Maria Grazia Giansanti

Förderung

  • Italian Association for Cancer Research
  • Ministero dell'università e della ricerca
  • Fondazione AIRC per la Ricerca sul Cancro
  • Italian Ministry of University and Research (MUR) as the Scientific Research Program of Relevant National Interest

Zitieren

APA

Frappaolo, A., Zaccagnini, G., & Giansanti, M. G. (2025). GOLPH3-mTOR Crosstalk and Glycosylation: A Molecular Driver of Cancer Progression. Cells, 14(6), 439. https://doi.org/10.3390/cells14060439

Vancouver

Frappaolo A, Zaccagnini G, Giansanti MG. GOLPH3-mTOR Crosstalk and Glycosylation: A Molecular Driver of Cancer Progression. Cells. 2025;14(6):439. doi:10.3390/cells14060439

BibTeX
@article{Frappaolo2025,
  author = {Frappaolo, Anna and Zaccagnini, Gianluca and Giansanti, Maria Grazia},
  title = {GOLPH3-mTOR Crosstalk and Glycosylation: A Molecular Driver of Cancer Progression},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {6},
  pages = {439},
  doi = {10.3390/cells14060439}
}
Kostenlos starten →